CD14 and hereditary angioedema: A similar trend was observed for BR2 expression on CD14++CD16− for HAE patients during the attack (85.49%; 53.60–98.46%) in comparison to remission state (80.55%; 35.28–95.97%; p = 0.457) and healthy subjects (68.96%; 29.76–95.00%; p = 0.0144; Figure 4/Table 2).